glp 1 cardiovascular risk reduction How do GLP-1 RAs and dual agonists impact residual risk? Watch this on-demand R3i webinar featuring Prof. Michel Hermans and Prof. Peter Libby. The webinar reviews evidence from major CVOTs and The cardiovascular effects of GLP-1
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























